Dimensional Fund Advisors
RUBY

Dimensional Fund Advisors’s Rubius Therapeutics, Inc RUBY Stock Holding History

Dimensional Fund Advisors’s Portfolio RUBY Stock Details RUBY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-20,222
Closed -$17K – 3548
2022
Q2 		$17K Sell
20,222
-16,254
-45% -$27.3K ﹤0.01% 3449
2022
Q1 		$201K Hold
36,476
– – ﹤0.01% 3310
2021
Q4 		$353K Buy
36,476
+436
+1% +$6.05K ﹤0.01% 3237
2021
Q3 		$644K Buy
36,040
+18,283
+103% +$398K ﹤0.01% 3130
2021
Q2 		$433K Hold
17,757
– – ﹤0.01% 3192
2021
Q1 		$471K Buy
17,757
+5,196
+41% +$75.9K ﹤0.01% 3154
2020
Q4 		$95K Buy
+12,561
New +$74.6K ﹤0.01% 3280

Other funds holding RUBY

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Dimensional Fund Advisors's RUBY Position: Q3 2022 in Review

Dimensional Fund Advisors sold out of Rubius Therapeutics, Inc (RUBY) in Q3 2022, closing a stake of 20,222 shares — an estimated $17K sold.

Dimensional Fund Advisors first reported a position in RUBY in Q4 2020 and held it in 7 quarters. The position peaked at $644K in Q3 2021. 62 funds tracked by Wall St. Rank hold RUBY as of Q3 2022.

  • Dimensional Fund Advisors reported no remaining Rubius Therapeutics, Inc position as of Q3 2022 after selling out during the quarter.
  • Dimensional Fund Advisors sold 20,222 Rubius Therapeutics, Inc shares in Q3 2022, an estimated $17K.
  • Dimensional Fund Advisors first reported a position in Rubius Therapeutics, Inc in Q4 2020 and held it in 7 quarters.
  • Dimensional Fund Advisors's Rubius Therapeutics, Inc position peaked at $644K in Q3 2021.
  • 62 funds tracked by Wall St. Rank held Rubius Therapeutics, Inc as of Q3 2022.

Based on Dimensional Fund Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.